A5065821297- Cardiac Arrhythmias and Treatments
- Cardiac pacing and defibrillation studies
- Atrial Fibrillation Management and Outcomes
- Cardiac electrophysiology and arrhythmias
- Cardiac Structural Anomalies and Repair
- Cardiac Valve Diseases and Treatments
- Cardiac Arrest and Resuscitation
- Cardiovascular Effects of Exercise
- Electrostatic Discharge in Electronics
- Medical Device Sterilization and Disinfection
- Pituitary Gland Disorders and Treatments
- Pain Management and Treatment
- Mechanical Circulatory Support Devices
- Traumatic Brain Injury Research
- Plasma and Flow Control in Aerodynamics
- Electromagnetic Fields and Biological Effects
- Traumatic Brain Injury and Neurovascular Disturbances
- Cardiac Health and Mental Health
- Healthcare Technology and Patient Monitoring
- Growth Hormone and Insulin-like Growth Factors
- Wireless Power Transfer Systems
- Robot Manipulation and Learning
- Wireless Body Area Networks
- Congenital Heart Disease Studies
- Neurological disorders and treatments
Montreal Heart Institute
2008-2024
Université de Montréal
2008-2024
Poznan University of Medical Sciences
2016
Abstract In the last three decades, ablation of atrial fibrillation (AF) has become an evidence-based safe and efficacious treatment for managing most common cardiac arrhythmia. 2007, first joint expert consensus document was issued, guiding healthcare professionals involved in catheter or surgical AF ablation. Mounting research evidence technological advances have resulted a rapidly changing landscape field ablation, thus stressing need regularly updated versions this partnership which were...
Background: Atrial fibrillation (AF) and heart failure (HF) frequently coexist can be challenging to treat. Pharmacologically based rhythm control of AF has not proven superior rate control. Ablation-based was compared with evaluate if clinical outcomes in patients HF could improved. Methods: This a multicenter, open-label trial blinded outcome evaluation using central adjudication committee. Patients high-burden paroxysmal (>4 episodes 6 months) or persistent (duration <3 years) AF,...
In the last three decades, ablation of atrial fibrillation (AF) has become an evidence-based safe and efficacious treatment for managing most common cardiac arrhythmia. 2007, first joint expert consensus document was issued, guiding healthcare professionals involved in catheter or surgical AF ablation. Mounting research evidence technological advances have resulted a rapidly changing landscape field ablation, thus stressing need regularly updated versions this partnership which were issued...
In the last three decades, ablation of atrial fibrillation (AF) has become an evidence-based safe and efficacious treatment for managing most common cardiac arrhythmia. 2007, first joint expert consensus document was issued, guiding healthcare professionals involved in catheter or surgical AF ablation. Mounting research evidence technological advances have resulted a rapidly changing landscape field ablation, thus stressing need regularly updated versions this partnership which were issued...
The ultra-low-temperature cryoablation (ULTC) ablation system using -196°C N2 cryogen has been reported to create lesions with freeze duration-dependent depth titratable over 10 mm minimum attenuation by scar. Cryocure-VT (NCT04893317) was a first-in-human clinical trial evaluating the safety and efficacy of novel, purpose-built ULTC catheter in endocardial scar-dependent ventricular tachycardias (VTs).
Ablation of ventricular tachycardia (VT) is limited by the inability to create penetrating lesions reach intramyocardial origins. Intramural needle ablation using in-catheter, heated saline-enhanced radio frequency (SERF) energy uses convective heating increase heat transfer and produce deeper, controllable at intramural targets. This first-in-human trial was designed evaluate safety efficacy SERF in patients with refractory VT.
Access to pacemakers and defibrillators is problematic in places with limited resources. Resterilization reuse of implantable cardiac devices obtained post mortem from patients wealthier nations have been undertaken, but uncertainty around the risk infection a concern.A multinational program was initiated 1983 provide tested resterilized underserved nations; prospective registry established 2003. Patients who received reused this were matched 1:3 ratio control new implanted Canada. The...
To allow timely initiation of anticoagulation therapy for the prevention stroke, European guidelines on atrial fibrillation (AF) recommend remote monitoring (RM) device-detected high-rate episodes (AHREs) and progression arrhythmia duration along pre-specified strata (6 min…<1 h, 1 h…<24 ≥ 24 h). We used MATRIX registry data to assess capability a single-lead implantable cardioverter-defibrillator (ICD) with sensing dipole (DX ICD system) follow this recommendation in patients standard...
Abstract Cardiac implantable electronic devices (CIED) are vulnerable to radio frequency (RF) cyber-attacks. Besides, CIED communicate with medical equipment whose telemetry capabilities and IP connectivity creating new entry points that may be used by attackers. Therefore, it remains crucial perform a cybersecurity risk assessment of the systems they rely on determine gravity threats, address riskiest ones priority basis, develop effective management plans. In this study, we carry out such...
Background There is no scientific literature that examines radiofrequency (RF) interference from Smart Meters with cardiac implantable electronic devices (CIEDs). The objective of this in vitro study was to assess any potential Medtronic CIEDs (Medtronic Inc., Minneapolis, MN, USA). Methods In the Quebec testing, five models were placed an acrylic cylinder filled a saline solution and faced Landis+Gyr Meter or Router (Landis+Gyr AG, Zug, Switzerland). distance between meter casing router...